Stentrode is the only implantable brain-computer interface that does not require open brain surgery and is currently in clinical trials SAN FRANCISCO & NEW YORK & MELBOURNE, Australia--(BUSINESS WIRE) ...
NEW YORK--(BUSINESS WIRE)--Synchron, a brain computer interface (BCI) company, today announced the results from a study in which four people with ALS received an implant of Synchron’s Stentrode™ ...
Apple has teamed up with Synchron to develop tech that lets people control its devices with thoughts
Apple has partnered with brain-computer interface maker Synchron to develop tech that lets consumers control devices like iPhones with their thoughts, according to a report by the Wall Street Journal.
Synchron Inc.'s recent $2 million raise for its Stentrode brain-computer interface platform comes at a pivotal time for the technology. Advances in BCI development, ongoing clinical trials and growing ...
Brain-Computer Interfaces (BCIs) are emerging as transformative tools that enable direct communication between the human brain and external devices. With recent advancements in Electroencephalography ...
Apple is collaborating with brain-computer interface company Synchron to develop technology that lets users control devices using neural signals. “This marks a defining moment for human-device ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results